RWS Holdings plc Share Price London S.E.
Equities
GB0033673939
Business Support Services
End-of-day quote
Other stock markets
|
||
- GBX | - |
05-07 | AstraZeneca target raised; Antofagasta lowered | AN |
05-02 | Deutsche Bank likes TP ICAP but says sell CMC | AN |
Sales 2024 * | 739M 940M 73.85B | Sales 2025 * | 768M 978M 76.79B | Capitalization | 692M 881M 69.17B |
---|---|---|---|---|---|
Net income 2024 * | 43M 54.75M 4.3B | Net income 2025 * | 55M 70.03M 5.5B | EV / Sales 2024 * | 0.94 x |
Net Debt 2024 * | 92.41K 118K 9.24M | Net cash position 2025 * | 35.87M 45.67M 3.59B | EV / Sales 2025 * | 0.85 x |
P/E ratio 2024 * |
15.7
x | P/E ratio 2025 * |
11.9
x | Employees | - |
Yield 2024 * |
6.62% | Yield 2025 * |
7.17% | Free-Float | 75.14% |
Latest transcript on RWS Holdings plc
Managers | Title | Age | Since |
---|---|---|---|
Ian El-Mokadem
CEO | Chief Executive Officer | 56 | 18/07/21 |
Candida Davies
DFI | Director of Finance/CFO | 50 | 02/10/22 |
Jim McHugh
HRO | Human Resources Officer | - | 31/12/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gordon Stuart
BRD | Director/Board Member | 61 | 03/11/20 |
David Clayton
BRD | Director/Board Member | 67 | 03/11/20 |
Andrew Brode
BRD | Director/Board Member | 84 | 10/04/00 |
1st Jan change | Capi. | |
---|---|---|
+16.14% | 71.02B | |
+6.93% | 17.38B | |
+12.92% | 13.88B | |
+19.72% | 13.49B | |
+15.69% | 10.07B | |
-19.12% | 7.08B | |
-2.02% | 6.12B | |
+3.92% | 5.3B | |
+0.94% | 5.06B |